Autophagy impairment in liver CD11c
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
17 03 2022
17 03 2022
Historique:
received:
13
10
2020
accepted:
23
02
2022
entrez:
18
3
2022
pubmed:
19
3
2022
medline:
6
4
2022
Statut:
epublish
Résumé
There has been a global increase in rates of obesity with a parallel epidemic of non-alcoholic fatty liver disease (NAFLD). Autophagy is an essential mechanism involved in the degradation of cellular material and has an important function in the maintenance of liver homeostasis. Here, we explore the effect of Autophagy-related 5 (Atg5) deficiency in liver CD11c
Identifiants
pubmed: 35301333
doi: 10.1038/s41467-022-29174-y
pii: 10.1038/s41467-022-29174-y
pmc: PMC8931085
doi:
Substances chimiques
Interleukin-23
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1440Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL144790
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL159804
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151769
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK117004
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK048522
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025786
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151493
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK106491
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145813
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES021801
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
Younossi, Z. M. Non-alcoholic fatty liver disease—a global public health perspective. J. Hepatol. 70, 531–544 (2019).
pubmed: 30414863
doi: 10.1016/j.jhep.2018.10.033
Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: The State of the Disease. Gastroenterology 158, 1851–1864 (2020).
pubmed: 32061595
doi: 10.1053/j.gastro.2020.01.052
Yang, Z. & Klionsky, D. J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 22, 124–131 (2010).
pubmed: 20034776
doi: 10.1016/j.ceb.2009.11.014
Yang, Z. & Klionsky, D. J. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol. 335, 1–32 (2009).
pubmed: 19802558
pmcid: 2832191
Yang, Z. & Klionsky, D. J. Eaten alive: a history of macroautophagy. Nat. Cell Biol. 12, 814–822 (2010).
pubmed: 20811353
pmcid: 3616322
doi: 10.1038/ncb0910-814
Painter, J. D., Galle-Treger, L. & Akbari, O. Role of autophagy in lung inflammation. Front. Immunol. 11, 1337 (2020).
pubmed: 32733448
pmcid: 7358431
doi: 10.3389/fimmu.2020.01337
Czaja, M. J. et al. Functions of autophagy in normal and diseased liver. Autophagy 9, 1131–1158 (2013).
pubmed: 23774882
pmcid: 3748187
doi: 10.4161/auto.25063
Liu, H.-Y. et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J. Biol. Chem. 284, 31484–31492 (2009).
pubmed: 19758991
pmcid: 2781544
doi: 10.1074/jbc.M109.033936
Yang, L., Li, P., Fu, S., Calay, E. S. & Hotamisligil, G. S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 11, 467–478 (2010).
pubmed: 20519119
pmcid: 2881480
doi: 10.1016/j.cmet.2010.04.005
Koga, H., Kaushik, S. & Cuervo, A. M. Altered lipid content inhibits autophagic vesicular fusion. FASEB J. 24, 3052–3065 (2010).
pubmed: 20375270
pmcid: 2909278
doi: 10.1096/fj.09-144519
Inami, Y. et al. Hepatic steatosis inhibits autophagic proteolysis via impairment of autophagosomal acidification and cathepsin expression. Biochem. Biophys. Res. Commun. 412, 618–625 (2011).
pubmed: 21856284
doi: 10.1016/j.bbrc.2011.08.012
Itoh, M. et al. CD11c
pmcid: 5752377
doi: 10.1172/jci.insight.92902
Wentworth, J. M. et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59, 1648–1656 (2010).
pubmed: 20357360
pmcid: 2889764
doi: 10.2337/db09-0287
Parker, R. et al. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. Am. J. Physiol. 314, G483–G493 (2018).
Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005).
pubmed: 15657292
pmcid: 2212798
doi: 10.1084/jem.20041257
Suzuki, Y. et al. Lack of autophagy induces steroid resistant airway inflammation. J. Allergy Clin. Immunol. 137, 1382–1389.e9 (2016).
pubmed: 26589586
doi: 10.1016/j.jaci.2015.09.033
Moylan, C. A. et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatology 59, 471–482 (2014).
pubmed: 23913408
doi: 10.1002/hep.26661
Calcinotto, A. et al. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature 559, 363–369 (2018).
pubmed: 29950727
pmcid: 6461206
doi: 10.1038/s41586-018-0266-0
Krause, P. et al. IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis. Nat. Commun. 6, 7055 (2015).
pubmed: 25959063
doi: 10.1038/ncomms8055
Siersbæk, M. et al. High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss. Sci. Rep. 7, 40220 (2017).
pubmed: 28071704
pmcid: 5223143
doi: 10.1038/srep40220
Remmerie, A. et al. Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity 53, 641–657.e14 (2020).
pubmed: 32888418
pmcid: 7501731
doi: 10.1016/j.immuni.2020.08.004
Tang, P. et al. Protective function of mitogen-activated protein kinase phosphatase 5 in aging- and diet-induced hepatic steatosis and steatohepatitis. Hepatol. Commun. 3, 748–762 (2019).
pubmed: 31168510
pmcid: 6546013
doi: 10.1002/hep4.1324
Yang, L. et al. Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II. Mol. Immunol. 51, 51–56 (2012).
pubmed: 22387269
doi: 10.1016/j.molimm.2012.02.004
Li, Y. et al. Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp. Mol. Pathol. 84, 1–8 (2008).
pubmed: 18054783
doi: 10.1016/j.yexmp.2007.09.004
Huang, T. et al. CRL4DCAF2 negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis. J. Exp. Med 215, 1999–2017 (2018).
pubmed: 30018073
pmcid: 6080916
doi: 10.1084/jem.20180210
Cho, M.-L. et al. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652–5661 (2006).
pubmed: 16622035
doi: 10.4049/jimmunol.176.9.5652
Otomo, C., Metlagel, Z., Takaesu, G. & Otomo, T. Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy. Nat. Struct. Mol. Biol. 20, 59–66 (2013).
pubmed: 23202584
doi: 10.1038/nsmb.2431
Dela Peña, A. et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129, 1663–1674 (2005).
doi: 10.1053/j.gastro.2005.09.004
Darlyuk-Saadon, I. et al. Active p38α causes macrovesicular fatty liver in mice. Proc. Natl Acad. Sci. USA 118, e2018069118 (2021).
pubmed: 33811139
pmcid: 8040811
doi: 10.1073/pnas.2018069118
Kotze, P. G., Ma, C., Almutairdi, A. & Panaccione, R. Clinical utility of ustekinumab in Crohn’s disease. J. Inflamm. Res 11, 35–47 (2018).
pubmed: 29445293
pmcid: 5810512
doi: 10.2147/JIR.S157358
Reich, K. et al. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet 394, 831–839 (2019).
pubmed: 31402114
doi: 10.1016/S0140-6736(19)31773-8
Feagan, B. G. et al. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn’s disease: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 389, 1699–1709 (2017).
pubmed: 28411872
doi: 10.1016/S0140-6736(17)30570-6
Ni, H.-M. et al. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. J. Hepatol. 61, 617–625 (2014).
pubmed: 24815875
pmcid: 4143992
doi: 10.1016/j.jhep.2014.04.043
Lin, C.-W. et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J. Hepatol. 58, 993–999 (2013).
pubmed: 23339953
pmcid: 3634371
doi: 10.1016/j.jhep.2013.01.011
Lieber, C. S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34, 9–19 (2004).
pubmed: 15670660
doi: 10.1016/j.alcohol.2004.07.008
Germic, N., Frangez, Z., Yousefi, S. & Simon, H.-U. Regulation of the innate immune system by autophagy: monocytes, macrophages, dendritic cells and antigen presentation. Cell Death Differ. 26, 715–727 (2019).
pubmed: 30737475
pmcid: 6460400
doi: 10.1038/s41418-019-0297-6
Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264–268 (2008).
pubmed: 18849965
doi: 10.1038/nature07383
Pu, Q. et al. Atg7 deficiency intensifies inflammasome activation and pyroptosis in pseudomonas sepsis. J. Immunol. 198, 3205–3213 (2017).
pubmed: 28258192
doi: 10.4049/jimmunol.1601196
Bechelli, J. et al. Atg5 supports rickettsia australis infection in macrophages in vitro and in vivo. Infect. Immun. 87, e00651-18 (2019).
Takeshita, F., Kobiyama, K., Miyawaki, A., Jounai, N. & Okuda, K. The non-canonical role of Atg family members as suppressors of innate antiviral immune signaling. Autophagy 4, 67–69 (2008).
pubmed: 17921696
doi: 10.4161/auto.5055
Jounai, N. et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl Acad. Sci. USA 104, 14050–14055 (2007).
pubmed: 17709747
pmcid: 1955809
doi: 10.1073/pnas.0704014104
Yousefi, S. et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell Biol. 8, 1124–1132 (2006).
pubmed: 16998475
doi: 10.1038/ncb1482
Betin, V. M. S. & Lane, J. D. Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J. Cell Sci. 122, 2554–2566 (2009).
pubmed: 19549685
pmcid: 2704886
doi: 10.1242/jcs.046250
Baerga, R., Zhang, Y., Chen, P.-H., Goldman, S. & Jin, S. Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice. Autophagy 5, 1118–1130 (2009).
pubmed: 19844159
doi: 10.4161/auto.5.8.9991
Zhang, Y. et al. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc. Natl Acad. Sci. USA 106, 19860–19865 (2009).
pubmed: 19910529
pmcid: 2785257
doi: 10.1073/pnas.0906048106
Dreux, M. & Chisari, F. V. Impact of the autophagy machinery on hepatitis C virus infection. Viruses 3, 1342–1357 (2011).
pubmed: 21994783
pmcid: 3185811
doi: 10.3390/v3081342
Mathur, R. et al. Induction of autophagy in Cx3cr1+ mononuclear cells limits IL-23/IL-22 axis-mediated intestinal fibrosis. Mucosal Immunol. 12, 612–623 (2019).
pubmed: 30765845
pmcid: 6927046
doi: 10.1038/s41385-019-0146-4
Sun, R. & Abraham, C. IL23 promotes antimicrobial pathways in human macrophages, which are reduced with the IBD-protective IL23R R381Q variant. Cell Mol. Gastroenterol. Hepatol. 10, 673–697 (2020).
pubmed: 32474165
pmcid: 7490566
doi: 10.1016/j.jcmgh.2020.05.007
Gomez Perdiguero, E. et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518, 547–551 (2015).
pubmed: 25470051
doi: 10.1038/nature13989
Sierro, F. et al. A liver capsular network of monocyte-derived macrophages restricts hepatic dissemination of intraperitoneal bacteria by neutrophil recruitment. Immunity 47, 374–388.e6 (2017).
pubmed: 28813662
doi: 10.1016/j.immuni.2017.07.018
Rohr, M. W., Narasimhulu, C. A., Rudeski-Rohr, T. A. & Parthasarathy, S. Negative effects of a high-fat diet on intestinal permeability: a review. Adv. Nutr. 11, 77–91 (2020).
pubmed: 31268137
Henning, J. R. et al. Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology 58, 589–602 (2013).
pubmed: 23322710
doi: 10.1002/hep.26267
Tran, S. et al. Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity 53, 627–640.e5 (2020).
pubmed: 32562600
doi: 10.1016/j.immuni.2020.06.003
Daemen, S. et al. Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep. 34, 108626 (2021).
pubmed: 33440159
pmcid: 7877246
doi: 10.1016/j.celrep.2020.108626
McGovern, D. & Powrie, F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 56, 1333–1336 (2007).
pubmed: 17872562
pmcid: 2000291
doi: 10.1136/gut.2006.115402
Arnold, I. C. et al. CD11c(+) monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23. Mucosal Immunol. 9, 352–363 (2016).
pubmed: 26242598
doi: 10.1038/mi.2015.65
Ganguly, S. et al. Nonalcoholic steatohepatitis and HCC in a hyperphagic mouse accelerated by western diet. Cell Mol. Gastroenterol. Hepatol. 12, 891–920 (2021).
pubmed: 34062281
pmcid: 8342972
doi: 10.1016/j.jcmgh.2021.05.010
Galle-Treger, L. et al. Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes. Nat. Commun. 10, 713 (2019).
pubmed: 30755607
pmcid: 6372786
doi: 10.1038/s41467-019-08449-x
Hurrell, B. P. et al. TNFR2 signaling enhances ILC2 survival, function, and induction of airway hyperreactivity. Cell Rep. 29, 4509–4524.e5 (2019).
pubmed: 31875557
pmcid: 6940205
doi: 10.1016/j.celrep.2019.11.102
Galle-Treger, L. et al. Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function. J. Allergy Clin. Immunol. 145, 502–517. e5 (2019).
Helou, D. G. et al. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity. J. Allergy Clin. Immunol. https://doi.org/10.1016/j.jaci.2021.05.042 (2021).
Helou, D. G. et al. Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis. PLOS Negl. Trop. Dis. 15, e0009627 (2021).
pubmed: 34403413
pmcid: 8370633
doi: 10.1371/journal.pntd.0009627
Helou, D. G. et al. PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity. Nat. Commun. 11, 3998 (2020).
pubmed: 32778730
pmcid: 7417739
doi: 10.1038/s41467-020-17813-1
Shafiei-Jahani, P. et al. DR3 stimulation of adipose resident ILC2s ameliorates type 2 diabetes mellitus. Nat. Commun. 11, 4718 (2020).
pubmed: 32948777
pmcid: 7501856
doi: 10.1038/s41467-020-18601-7
Howard, E. et al. IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates cellular metabolism and ameliorates airway hyperreactivity. J. Allergy Clin. Immunol. https://doi.org/10.1016/j.jaci.2020.08.024 (2020).